Immunotherapy of Cancer: Regression of Tumors after Intralesional Injection of Living Mycobacterium bovis
- 16 April 1971
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 172 (3980), 271-273
- https://doi.org/10.1126/science.172.3980.271
Abstract
Injection of living Mycobacterium bovis (strain BCG) into established intradermal tumors caused tumor regression and prevented the development of metastases.Keywords
This publication has 6 references indexed in Scilit:
- Tumor Immunity Produced by the Intradermal Inoculation of Living Tumor Cells and Living Mycobacterium bovis (Strain BCG)Science, 1970
- Use of Vaccinia Virus in the Treatment of Metastatic Malignant MelanomaBMJ, 1970
- Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesionsCancer, 1970
- Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.British Journal of Cancer, 1969
- Effect of BCG and Allogeneic Tumour Cells on Adenovirus Type 12 Tumorigenesis in MiceNature, 1969
- STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A METHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG)The Journal of Experimental Medicine, 1966